Dentsply Sirona (XRAY) Current Deferred Revenue (2009 - 2021)
Dentsply Sirona posted quarterly Current Deferred Revenue of $68.0 million for Q4 2021, up 28.3% year-on-year from $53.0 million in Q4 2020, and up 28.3% on a QoQ basis from $53.0 million in Q4 2020.
Dentsply Sirona (XRAY) has 4 years of Current Deferred Revenue data on file, last reported at $68.0 million in Q4 2021.
- For the quarter ending Q4 2021, Current Deferred Revenue rose 28.3% year-over-year to $68.0 million; the trailing twelve-month figure through Dec 2021 stood at $68.0 million (up 28.3% YoY), and the FY2021 full-year result was $68.0 million, up 28.3% from the prior year.
- Current Deferred Revenue for Q4 2021 stood at $68.0 million, up from $53.0 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $68.0 million in Q4 2021 and bottomed at $53.0 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Dentsply Sirona | 1.99 Bn | 1.80 Bn | 427.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 68.00 Mn |
| Dec 31, 2020 | 53.00 Mn |
| Dec 31, 2010 | 5.66 Mn |
| Dec 31, 2009 | 3.39 Mn |